Investors



  • FOR INFORMATION ON
    REPORTING CHANGES AND
    REVISED REVENUE GUIDANCE click here.


  • FOR GIVEN IMAGING
    ACQUISITION INFORMATION, click here.


  • FOR 2013 INVESTOR DAY MATERIALS,
    click here.


  • For Pharmaceuticals
    spin-off information,
    click here.


  • For tax basis information
    due to the Mallinckrodt spin,
    click here.


News Release

Printer Friendly Version View printer-friendly version
<< Back
Covidien to Host Investor Meeting on September 8, 2011

DUBLIN, Jul 08, 2011 (BUSINESS WIRE) -- Covidien (NYSE: COV), a leading global provider of healthcare products, will host an investor meeting on Thursday, September 8, 2011, to update the investment community on the Company and its growth initiatives, strategic priorities and financial outlook. The event, held at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY, will begin around noon and is expected to conclude by 5:00 p.m.

The program will include presentations by Covidien's President and CEO José (Joe) Almeida and other members of the senior management team. A more detailed agenda will be communicated prior to the meeting.

Advanced registration is required and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website: http://survey.covidien.com/survey/375951/1bd6

Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at Covidien's website: http://investor.covidien.com. A replay of the presentations and the presentation materials will be available at the same website following the conclusion of the meeting.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit http://www.covidien.com to learn more about our business.

SOURCE: Covidien

Covidien
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
eric.kraus@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Todd Carpenter, 508-452-4363
Director
Investor Relations
todd.carpenter@covidien.com